Rivas Medical Weight Loss

Rivas Medical Weight Loss operates a physician-supervised weight loss clinic in Towson, Maryland, with telehealth services extending to patients in Virginia and Florida. The practice focuses exclusively on medical weight management through GLP-1 receptor agonist peptide therapies, offering both semaglutide and tirzepatide as primary treatment options for patients seeking clinically-proven weight reduction interventions. With a 4.9-star rating across 392 Google reviews, the clinic has established a track record in the Baltimore metropolitan area for structured, medication-assisted weight loss programs that address the physiological mechanisms underlying obesity and metabolic dysfunction.

The clinic's treatment protocols center on two FDA-approved GLP-1 peptides: semaglutide, which mimics the glucagon-like peptide-1 hormone to regulate appetite and glucose metabolism, and tirzepatide, a dual GIP/GLP-1 receptor agonist that targets both glucose-dependent insulinotropic polypeptide and GLP-1 pathways for enhanced metabolic effects. Patients receive individualized dosing schedules that begin with lower introductory doses and titrate upward based on tolerance and response, a protocol designed to minimize gastrointestinal side effects while optimizing therapeutic outcomes. The medical team integrates these peptide therapies with nutritional counseling that addresses macronutrient balance, caloric targets, and behavioral modifications necessary for sustained weight management beyond the medication phase. Metabolic testing is incorporated into initial assessments to identify underlying factors such as insulin resistance, thyroid dysfunction, or hormonal imbalances that may complicate weight loss efforts.

The physician-led approach at Rivas Medical Weight Loss means that all treatment plans are developed and monitored by licensed medical doctors who evaluate patient candidacy for GLP-1 therapy based on BMI, comorbid conditions, previous weight loss attempts, and contraindications. Patients undergo comprehensive initial consultations that include medical history review, current medication assessment, and discussion of realistic weight loss goals aligned with clinical guidelines. The practice's front office and clinical team coordinate ongoing care through regular follow-up appointments—available both in-person at the Towson location and via telehealth for Maryland, Virginia, and Florida residents—to adjust dosing, address side effects, and track progress through objective metrics including weight, body composition, and metabolic markers.

Patients report that the clinic's structured approach includes clear communication about what to expect at each phase of treatment, from initial consultation through maintenance dosing. The intake process involves detailed discussion of how GLP-1 peptides function, potential side effects such as nausea or decreased appetite, and the importance of adherence to both medication schedules and nutritional recommendations. Follow-up visits focus on dose adjustments based on individual response, with the medical team providing specific guidance on managing common challenges such as plateaus, medication tolerance, or the transition from active weight loss to weight maintenance. The front desk staff coordinates prescription fulfillment, insurance verification where applicable, and scheduling for ongoing monitoring visits that track both subjective patient experience and objective clinical outcomes.

Rivas Medical Weight Loss differentiates itself through exclusive focus on medical weight management rather than a broad wellness practice, allowing the clinical team to develop deep expertise in GLP-1 peptide therapy protocols and the nuances of dose optimization for diverse patient populations. The availability of both in-person care in Towson and telehealth services across three states provides flexibility for patients with scheduling constraints or those who prefer remote monitoring after initial in-person assessment. The clinic's patient volume, reflected in nearly 400 Google reviews, indicates operational systems designed to manage high patient throughput while maintaining individualized treatment plans, with specific attention to the questions and goals each patient brings to their weight loss journey. This combination of specialized medical focus, dual peptide options, and hybrid care delivery positions the practice as a dedicated resource for Baltimore-area residents and mid-Atlantic patients seeking physician-supervised GLP-1 therapy for weight management.